A Phase I Single-Dose Crossover Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy Of AMG 811 (anti-IFN-gamma) In Subjects With Discoid Lupus Erythematosus Werth, V. P., Fiorentino, D., Cohen, S. B., Fivenson, D., Hansen, C., Zoog, S., Arnold, G., Wang, C., Boedigheimer, M., Welcher, A., Chung, J., Sullivan, B., Martin, D. A. WILEY-BLACKWELL. 2013: S682–S683

View details for Web of Science ID 000325359204072